NoName Annual Performance 2023-2024

This year I gained 5.1%, bringing my CAGR to 33% since buying my first stock 11 years ago. I'm super happy and proud of my long term record, though losing to the S&P the past 4 years straight isn't great. I've been treading water recently and hopefully next year changes that.

NoName Annual Performance 2019-2020

Another incredible year!  I'm up 94.9%, giving me a CAGR of 52.5% since I started investing 7 years ago.  

    

****update Feb 21, 2021****

I made a calculation mistake when first writing this post.  My real return is 94.9%, not 85.3% which means my CAGR is really 52.5%, not 51.4%.  See comment at end of post for explanation.

You can read more on my performance in past annual posts here.

Biomerica is a Buy

Biomerica (BMRA) is a small developer of medical test equipment. They are working on FDA approval of their new product, InFoods, and describe it as a “multi billion dollar market opportunity.” With a market cap of $22M BMRA is in for big things if all goes as planned.

My Portfolio July 2016

I started this blog with the intention of posting an article about each stock purchase not long after I made it.  Well I have utterly failed.  I would love to blog more, not only for my readers but also myself.  I get to know, and remember, a company much better after writing so it's a big benefit to me personally to go through the blogging exercise.  Unfortunately life gets in the way.  I have a wife, kids, house, dog, full time job unrelated to stocks, '67 Firebird restoration a decade old, etc so I have to just accept my limitations. I've been averaging a little more than a post per month and that'll likely continue

This post is just going to be a list of my current portfolio.  I thought people out there might be interested.  I plan on writing posts on all of these stocks but who knows when I'll get to it.  I do have a post planned this week but 'planned' does not equal 'completed' so we'll see